EVP, Chief Financial Officer
Mon, Mar 3, 2025
Mar 3
exercised or converted securities in TEVA
49,800 shares @ $0.00
Decreased holdings by -33.30%
Option Exercise
Sale tied to a same-time option exercise
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
Health CarePharmaceuticals
1D0.00%
1W+0.96%
1M+19.47%
3M+6.36%
6M—
1Y—